There are 2.5 quintillion bytes of data created each day, resulting in your company’s digital footprint quickly growing at an exponential rate year after year. The scale and velocity of this growth creates a struggle for how organizations manage and secure all of that data. Unstructured data poses a unique challenge. Forty percent¹ of businesses say they need an effective way to manage their unstructured data on a daily basis.

Egnyte For Procore from Egnyte on Vimeo The construction industry is a field that requires a tremendous amount of collaboration. On any given day, a superintendent or foreman will read, revise, and share project-specific drawings, RFIs, submittals, change orders, and photos. With Egnyte and Procore, project managers can now review, revise, share, and approve of any needed documents captured by foremen and superintendents.

This week marks six months since the last of three compliance deadlines for the New York State Department of Financial Services (NYDFS) Cybersecurity Regulations. As of March 1, 2019, many financial services firms operating in New York state are now required to abide by a new set of cybersecurity standards that dictate how they manage, share, and control access to data.

Ransomware isn’t a new phenomenon, but it’s effects are starting to be felt more widely, and more deeply than ever before. Behemoths like Sony, Nissan, FedEx, Kraft Foods and Deutsche Bank have all been hit in recent years, and the list is growing. The ongoing saga of the ransomware attack in Baltimore, MD has left citizens unable to pay parking tickets or finalize property sales. American small businesses may bear the brunt of the impact of ransomware’s global spread.

Introduction Developing new drugs is an expensive, time-consuming endeavor. A critical output of the drug development process, besides the compound itself, is data. As you may have read recently, Zolgensma™ re-surfaced in the press because of supposed data manipulation in a specific animal testing procedure. Needless to say, this is a big deal.

Data drives the life sciences. Data supports the development of new products and enables agile decision making. But for a field so completely reliant on data, the industry is struggling to find methods to adequately handle that data. Ideally, there would be centralized repositories where data is accessible, safe, and organized regardless of the format or size. Instead, there are numerous data silos spread among the different contributors to a specific project.

Those who have worked in the life sciences industry have undoubtedly observed a sea of change in the discipline over the past twenty years. From new modalities (like CAR-T to microbiome) to external collaborations, the way drugs are developed in the 21st century is more complex, more distributed, and faster. Alongside fundamentally new discoveries is a pan-industry shift from on-premise computing to the cloud.

The California Consumer Protection Act (CCPA), set to go into effect in January 2020, will have a big impact on companies that do business in California or collect the personal information of California citizens. Driven by growing public demand for privacy, CCPA is the latest in a line of regulations that gives individuals greater control over how their personal data can be collected, stored, purchased, or shared by private companies. Wondering what CCPA means for your business?

The life sciences industry is responsible for the discovery, development, and commercialization of new medicines to treat disease. Over the past 20 years, the discipline has undergone massive changes.

The California Consumer Privacy Act of 2018, known as CCPA, is a data privacy law aimed at protecting the personal information of California consumers. Frequently compared to the UK’s expansive GDPR, CCPA will have a big impact on how companies collect, store, and process personal information of California consumers.